CIK: 0001687078
Total reported value
$1.3B
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | RPTX | Repare Therapeutics INC | Stock-Other | 19.70% | — | — | |
| 2 | ✓ | Stock-Other | 17.21% | — | — | ||
| 3 | TCRRUSD | Tcr2 Therapeutics INC | Stock-Other | 13.77% | — | — | |
| 4 | ✓ | MEI Pharma, Inc. | Stock-Other | 11.13% | — | +62.21% | |
| 5 | EPZMEUR | Epizyme INC | Stock-Other | 9.96% | — | — | |
| 6 | GTHXEUR | G1 Therapeutics INC | Stock-Other | 9.18% | — | — | |
| 7 | ✓ | Adc Therapeutics SA | Stock-Other | 6.72% | — | — | |
| 8 | TPB | Turning Point Brands, Inc. | Stock-Other | 5.30% | — | — | |
| 9 | YMABUSD | Y-mabs Therapeutics INC | Stock-Other | 3.87% | — | — | |
| 10 | ✓ | Merus N V | Stock-Other | 3.00% | — | — | |
| 11 | AUTL | Autolus Therapeutics PLC | Stock-Other | 0.17% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | MEI Pharma, Inc. | +5% | +62.21% | Add |
| 2 | AUTL | Autolus Therapeutics PLC | 0% | — | Unchanged |
| 3 | GTHXEUR | G1 Therapeutics INC | -0.4% | — | Unchanged |
| 4 | YMABUSD | Y-mabs Therapeutics INC | -1.5% | — | Unchanged |
| 5 | TCRRUSD | Tcr2 Therapeutics INC | -2.2% | — | Unchanged |
| 6 | TPB | Turning Point Brands, Inc. | -3.1% | — | Unchanged |
| 7 | ✓ | -10.4% | — | Unchanged | |
| 8 | EPZMEUR | Epizyme INC | -12.1% | — | Unchanged |
| 9 | RPTX | Repare Therapeutics INC | — | NEW | New buy |
| 10 | ✓ | Adc Therapeutics SA | — | NEW | New buy |
| 11 | ✓ | Merus N V | — | NEW | New buy |
| 12 | CTMX | Cytomx Therapeutics INC | — | EXIT | Sold out |
| 13 | SNSSEUR | Viracta Therapeutics INC | — | EXIT | Sold out |